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Introduction
The reproductive axis is controlled by gonadotropin-releasing hormone (GnRH), which is produced in hypothalamic neurons and secreted in a pulsatile fashion. Via the portal circulation it reaches the anterior pituitary and stimulates secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) through GnRH receptor (GnRH-R) activation [1, 2] . The gonadotropins target the gonads and regulate secretion of steroid hormones, like estrogen and progesterone [3] . During the last years, several studies have described effects by these hormones also on the gastrointestinal tract. GnRH analogs have been shown to inhibit gastric secretion and gastrin release in rat and dog [4, 5] , to inhibit cell proliferation of gastric epithelium [6] and smooth muscle cells [7] , and to induce apoptosis and inhibit cell proliferation in gastric cancer cells [3, 8] . Both GnRH analogs and LH have been shown to affect gastrointestinal motility in rat and man; GnRH analogs by stimulation of gastrointestinal motility and LH by prolonging and fragmenting of the phase III migrating motor complex (MMC) [9, 10, 11] .
The question remains whether the effects observed on the gastrointestinal tract by GnRH analogs are exerted directly by GnRH-R activation or indirectly through the pituitary gland. It needs to be determined whether the GnRH-induced effects are executed by activation of intestinal GnRH receptors, or if it is executed by way of systemic LH release and subsequently due to stimulation of LH receptors (LH-R). Before we can start to speculate on the mechanisms behind, we need to recognize possible tissue expression of the peptides of interest. Recently, our research group described GnRH expression in human submucous and myenteric neurons in both small and large intestine [12] . In rat, presence of GnRH and GnRH-R have been suggested in several cell types of the gastrointestinal tract [5, 7, 13, 14] , whereas such expression could not be confirmed by our group [15] . Notably, LH-R was found to be expressed in enteric neurons in rat stomach, small and large intestine [15] . The aim of the present study was to study the possible expressions of GnRH, LH, and FSH as well as their receptors in man and rat, by retrieving microarray data from public repositories, by using quantitative Real-Time polymerase chain reaction (qRT-PCR), and by immunocytochemistry, with particular focus on the gastrointestinal tract.
Material and methods

Microarray and qRT-PCR analysis
The Web-based software tool Genevestigator was used to evaluate gene expression across a variety of human tissues for all genes of interest [16] . 
Gastrointestinal tissue sampling
Patients were treated according to the Helsinki declaration and the studies were approved by the Ethics Committee, Lund/Malmö. Written, informed consent was obtained from the patients prior surgery. One male and ten female Sprague-Dawley rats (170-300 g), purchased from Charles River, Sulzfeld, Germany, were used. The rats were allowed to acclimatize to the climate-and light-controlled animal facility for at least five days prior experimentation.
Standard rat chow and water were supplied at all times. The experimental design was approved by the animal ethics committee, Lund and Malmö, Sweden. Animals were used in accordance with the European Communities Council Directive (2010/63/EU) and the Swedish Animal Welfare Act (SFS 1988:534) .
Man
Paraffin sections of ileum from one man (20 years of age) diagnosed with enteric inflammatory neuropathy [12, 17] and from one woman (30 years of age) diagnosed with enteric degenerative neuropathy [12, 18] were used for immunocytochemistry. In addition, ileum tissue was collected from one woman (84 years of age) undergoing gastrointestinal surgery due to sigmoideum diverticulosis, and colonic tissue from one woman (65 years of age) with non-obliterating adenocarcinoma of rectosigmoideum and one woman (68 years of age) due to sigmoideum diverticulosis. The latter three patients had no history of gastrointestinal dysmotility, and samples were taken from macroscopic normal areas 10 cm above the tumor, or in a diverticulosis free area. Tissue segments from both ileum and colon were rinsed in saline and fixed in Stefanini's fixative (a mixture of 2% formaldehyde and 0.2% picric acid in phosphate buffer, pH 7.2) or in 4% paraformaldehyde in 0.1 M phosphate buffer for 22 h at 4º C.
Rat
Rats were euthanized under deep anesthesia and the pituitary, stomach, ileum, colon, ovary, and testis were removed. The gut segments were rinsed in saline, opened and pinned flat on balsa wood. One portion of each tissue segment or organ was fixed in Stefanini's fixative for 
Statistical analyses
Results of the immunocytochemistry are presented as medians and spreads, expressed as 25 th and 75 th percentile.
Results
Quantification of gene expression in human tissues and the gastrointestinal tract
An initial characterization of mRNA expression was undertaken by using the web-based tool Genevestigator, examining the expression of human genes coding for GnRH 1 and 2 (GNRH1 and GNRH2), GnRH-R (GNRHR), LH (LHB), LH-R (LHCGR), FSH (FSHB), and FSH-R (FSHR). The results of this analysis, which includes published microarrays and gene expression data from more than 730 studies and 53,000 samples of human origin, are shown in Supplementary Figure S1 -S6. In this analysis, all examined genes in the present study were found to be expressed at low or very-low level in all human tissues, with the exception of LHB and FSHB in the pituitary gland, in which high expressions were detected.
In order to consolidate and expand these results, we also characterized the mRNA expression of all the above mentioned genes by qRT-PCR in a series of human tissues from different intestinal locations, including duodenum, jejunum, ileum, ileocecum, cecum, ascending and descending colon, and rectum, as well as brain as a tentative positive control.
No mRNA expression could be detected for GNRHR, LHCGR and FSHR in any of the tissues tested under our experimental conditions, while FSHB and LHB were found to be expressed, respectively, at low and very low levels only in the brain. Notably is that GnRH 1 and 2 (GNRH1 and GNRH2) were both detected in the human intestine, although with varying levels of expression along the gastrointestinal tract ( Figure 1) . Overall, the results from gene expression analyses suggest that GnRH-, LH-, and FSH receptors are expressed at extremely low levels, if at all, in the human gastrointestinal tract, while GnRH 1 and 2 can be found in detectable amounts. However, this analysis is only partially informative, because it does not allow cell-type specific analyses. Therefore, we set to further investigate this with immunocytochemistry.
Enteric neurons immunoreactive for the peptides and their receptors
GnRH receptor
No GnRH-R-IR nerve cell bodies or fibers were detected in human or rat gastrointestinal tract. In the rat pituitary, used as positive control for GnRH-R, the cell membrane of gonadotrophs displayed GnRH-R immunoreactivity.
LH and LH receptor
No LH-IR nerve cell bodies or fibers were detected in human or rat gastrointestinal tract.
In the rat pituitary, used as positive control for LH, the gonadotrophs´ cytoplasm displayed intense LH immunoreactivity. Rat ovary, used as positive control for LH-R, displayed numerous LH-R-IR granulosa cells.
LH-R immunoreactivity was found in enteric neurons in human ileum and colon and was quantified in three patients (Figure 2 ). In the patient diagnosed with inflammatory neuropathy with infiltration of lymphocytes (man 20 years of age), 29% of the submucous and 17% of the myenteric neurons in ileum displayed LH-R immunoreactivity. In ileum from a patient diagnosed with degenerative neuropathy (woman 30 years of age), the submucous neurons was too few to allow any quantification, while 11% of the myenteric neurons displayed LH-R immunoreactivity. In colon taken from one patient undergoing gastrointestinal surgery (woman 68 years of age), 17% of both submucous and myenteric neurons displayed LH-R immunoreactivity.
Intense LH-R immunoreactivity was found in enteric neurons throughout the rat gastrointestinal tract (Figure 2 ). The IR material was mainly located in nerve cell bodies. Few LH-R-IR fibers were found in the smooth muscle layers of fundus, ileum, and colon. In fundus, LH-R-IR submucous neurons were too few to allow quantification, but 8% of the myenteric neurons were LH-R-IR (Figure 2 ). In ileum, 4% of the submucous and 9% of the myenteric neurons, and in colon, 13% of submucous and 21% of myenteric neurons, displayed LH-R immunoreactivity, respectively (Figure 2 ).
No FSH-IR or FSH-R-IR nerve cell bodies or fibers were detected in human or rat gastrointestinal tract. In the rat pituitary, used as positive control for FSH immunoreactivity, the gonadotrophs´ cytoplasm displayed intense FSH immunoreactivity. Rat testis, used as positive control for FSH-R, displayed numerous FSH-R-IR sertoli cells.
Discussion
GnRH 1 and 2 mRNA were most abundantly expressed in the small intestine in the present study. The detection of intestinal mRNAs suggests a local translation of these peptides. Of the peptides (GnRH-R, LH, LH-R, FSH, and FSH-R) tested, only LH-R immuoreactivity was detected in rat stomach and small and large intestine from rat and man.
Both GnRH 1 and 2 are decapeptides and discriminated by different amino acids in position 5 to 8. The two peptides are identical in rat and man [19] . GnRH1 is a hormone which regulates the hypothalamic-pituitary axis and gonadotropin production [1, 2, 3] , whereas GnRH2 is a neuropeptide expressed in the brain, in particular hind brain and spinal cord, hence being extra-hypothalamic [20] . GnRH2 is believed to participate in the reproduction and sexual behavior through neuro-modulation [19, 21] . We do not know the role of GnRH 1 and 2 in the gastrointestinal tract. It may be that one acts as a hormone secreted into the blood circulation and one as a neuropeptide, in analogy with that found in brain, but this has to be further studied. Different receptors for GnRH 1 and 2 have been described in mammals although GnRH-R2 is not expressed as a fully functional receptor, due to a genomic stop sequence/frame shift [22, 23] . However, both GnRH1 and GnRH2 are able to signal through the type 1 receptor [19] . GnRH1 has a short half-life of 2-4 minutes, which, in combination with its secretion into the anatomically inaccessible portal circulation of the pituitary, has rendered sampling of GnRH very complicated [1, 2] . Instead, the downstreamsecreted LH is studied.
Previously, we reported expression of GnRH in submucous and myenteric neurons in human small and large intestine [12, 18] , while GnRH and GnRH-R-IR enteric neurons were absent in rat [15] . In contrast, other groups have found GnRH and GnRH-R immunoreactivity in rat enteric neurons, smooth muscle cells, and on parietal cells in the epithelium [5, 6, 7, 13] . Our antibodies were raised against synthetic GnRH1; possible cross-reactivity to GnRH2 has not been able to evaluate. Antibodies raised against GnRH2 are not commercially available. The GnRH antibodies used by others were produced by the groups themselves, and may differ in their affinity for GnRH2 and/or GnRH1 [5, 6, 7, 13] . The different results between our and others´ result may be explained by different affinity of antibodies to GnRH2. However, the PCR results in our present study suggest predominance of GnRH1 rather than GnRH2, at least in the human gut. Future efforts using in situ hybridization and/or other detection methods may further aid in revealing the cellular expressions and distributions of the peptides.
The GnRH-R and LH-R both have more than 80% amino acid homology between rat and man [24, 25] . LH-R has been demonstrated in submucous and myenteric neurons in small and large intestine, glia cells and endothelial cells in man [17] , while in rat LH-R-IR was exclusively confined to enteric neurons [15] . In the former publication, no absorption controls were performed in man, but our present findings confirm LH-R on submucous and myenteric neurons.
Our present and previous findings of GnRH and LH-R in human and LH-R in rat gastrointestinal tract [12, 15, 17, 18] , may provide an explanation for the small intestinal dysmotility noted after administration of GnRH analogs or LH [9, 10, 11] . Patients with enteric dysmotility and chronic intestinal pseudo-obstruction exhibit disturbances in small intestinal motility patterns [26, 27] . We have observed that such disorders can manifest themselves after repeated treatment with high doses of GnRH analogs, along with reduced number of GnRH-IR myenteric neurons and appearance of antibodies against GnRH in serum [12, 18] . Furthermore, intermittent administration of the GnRH analog buserelin to rats rendered up to 50% reduction of enteric neurons, accompanied with a down-regulation of the neuronal expression of LH-R [15] . Taken together, these findings raise the suspicion that GnRH and/or LH play pivotal roles in intestinal motility regulation.
Hormonal influence on gastrointestinal functions may explain a female predominance with respect to functional and motility disorders of the bowel [26, 27, 28] .
Furthermore, high titers of GnRH antibodies have been described in patients with such diseases [29] . Continuous treatment with the GnRH analog leuprolide was shown to improve symptoms in patients with functional bowel disorders [30, 31] . The mechanism behind is enigmatic, but may be due to down-regulation of the GnRH-R in the pituitary gland and subsequent depletion of gonadotropins and sex hormones [3] , suggested to influence gastrointestinal motility [32, 33] . Another plausible explanation to the leuprolide-induced effects is by activation of intestinal GnRH-R. Although we could not demonstrate any
GnRH-R expression in our samples, this does not exclude low levels of expression in subsets of intestinal cells.
Neither FSH nor FSH-R were detected in the gastrointestinal tract of man or rat, by any method used, why the role of FSH on the gastrointestinal function can be anticipated to be of minor or no importance.
Conclusions
GnRH1-and GnRH2 mRNA are expressed in human intestine. LH-R-IR enteric neurons are found along the entire gastrointestinal tract in both man and rat. GnRH or its receptor are not found in rat gastrointestinal tract, and neither FSH or its receptor is found in the gastrointestinal tract.
Legends of figures Figure 1 The relative expression of mRNA (arbitrary units) for gonadotropin-releasing hormone 1 and 2 (GnRH1 and GnRH2) in brain and human intestinal tract. Nd = non-detected. 
